Suppr超能文献

心脏肌球蛋白结合蛋白 C 中意义不确定变体致病性评估中的蛋白质热力学不稳定性。

Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C.

机构信息

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Federico II, Naples, Italy.

出版信息

J Cardiovasc Transl Res. 2020 Oct;13(5):867-877. doi: 10.1007/s12265-020-09959-6. Epub 2020 Feb 7.

Abstract

In the era of next generation sequencing (NGS), genetic testing for inherited disorders identifies an ever-increasing number of variants whose pathogenicity remains unclear. These variants of uncertain significance (VUS) limit the reach of genetic testing in clinical practice. The VUS for hypertrophic cardiomyopathy (HCM), the most common familial heart disease, constitute over 60% of entries for missense variants shown in ClinVar database. We have studied a novel VUS (c.1809T>G-p.I603M) in the most frequently mutated gene in HCM, MYBPC3, which codes for cardiac myosin-binding protein C (cMyBPC). Our determinations of pathogenicity integrate bioinformatics evaluation and functional studies of RNA splicing and protein thermodynamic stability. In silico prediction and mRNA analysis indicated no alteration of RNA splicing induced by the variant. At the protein level, the p.I603M mutation maps to the C4 domain of cMyBPC. Although the mutation does not perturb much the overall structure of the C4 domain, the stability of C4 I603M is severely compromised as detected by circular dichroism and differential scanning calorimetry experiments. Taking into account the highly destabilizing effect of the mutation in the structure of C4, we propose reclassification of variant p.I603M as likely pathogenic. Looking into the future, the workflow described here can be used to refine the assignment of pathogenicity of variants of uncertain significance in MYBPC3.

摘要

在下一代测序(NGS)时代,遗传性疾病的基因检测鉴定出越来越多的致病性仍不清楚的变体。这些意义不明的变体(VUS)限制了基因检测在临床实践中的应用。肥厚型心肌病(HCM)是最常见的家族性心脏病,其 VUS 占 ClinVar 数据库中显示的错义变体条目超过 60%。我们研究了一种新型 VUS(c.1809T>G-p.I603M),该变体位于 HCM 中最常突变的基因 MYBPC3 中,该基因编码心肌肌球蛋白结合蛋白 C(cMyBPC)。我们对致病性的确定综合了生物信息学评估和 RNA 剪接以及蛋白质热力学稳定性的功能研究。计算机预测和 mRNA 分析表明,该变体未引起 RNA 剪接的改变。在蛋白质水平上,p.I603M 突变位于 cMyBPC 的 C4 结构域。尽管该突变不会使 C4 结构域的整体结构发生很大变化,但圆二色性和差示扫描量热法实验表明 C4 I603M 的稳定性严重受损。考虑到突变对 C4 结构的高度不稳定作用,我们建议将变体 p.I603M 重新归类为可能的致病性。展望未来,这里描述的工作流程可用于细化 MYBPC3 中意义不明变体致病性的分配。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验